UroGen Pharma (URGN) Short Interest Ratio & Short Volume → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free URGN Stock Alerts $13.55 +0.29 (+2.19%) (As of 05/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends UroGen Pharma Short Interest DataCurrent Short Interest4,470,000 sharesPrevious Short Interest4,430,000 sharesChange Vs. Previous Month+0.90%Dollar Volume Sold Short$61.60 millionShort Interest Ratio13.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares23,450,000 sharesPercentage of Shares Shorted19.06%Today's Trading Volume332,164 sharesAverage Trading Volume326,122 sharesToday's Volume Vs. Average102% Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartURGN Short Interest Over TimeURGN Days to Cover Over TimeURGN Percentage of Float Shorted Over Time Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. UroGen Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20244,470,000 shares $61.60 million +0.9%N/A13.7 $13.78 4/30/20244,430,000 shares $61.22 million +5.5%N/A12.7 $13.82 4/15/20244,200,000 shares $63.42 million +0.2%N/A11.5 $15.10 3/31/20244,190,000 shares $62.85 million -1.4%N/A12.6 $15.00 3/15/20244,250,000 shares $61.46 million +8.1%N/A12.4 $14.46 2/29/20243,930,000 shares $72.04 million -2.0%N/A12.7 $18.33Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 2/15/20244,010,000 shares $75.39 million +23.0%N/A13.2 $18.80 1/31/20243,260,000 shares $51.18 million -3.8%N/A11 $15.70 1/15/20243,390,000 shares $49.46 million -4.5%N/A12.9 $14.59 12/31/20233,550,000 shares $53.25 million +15.6%N/A13.5 $15.00 12/15/20233,070,000 shares $46.05 million +5.1%N/A11.3 $15.00 11/30/20232,920,000 shares $38.51 million +3.2%N/A12.4 $13.19 11/15/20232,830,000 shares $32.77 million +23.6%N/A11.4 $11.58 10/31/20232,290,000 shares $25.67 million +39.6%N/A7.9 $11.21 10/15/20231,640,000 shares $21.48 million +14.7%N/A2.6 $13.10 9/30/20231,430,000 shares $20.03 million +10.9%N/A2.3 $14.01 9/15/20231,290,000 shares $20.52 million -8.5%N/A2.1 $15.91 8/31/20231,410,000 shares $24.65 million -15.1%N/A2.2 $17.48 8/15/20231,660,000 shares $37.12 million +5.7%N/A2.7 $22.36 7/31/20231,570,000 shares $34.01 million +55.5%N/A2.8 $21.66 7/15/20231,010,000 shares $9.28 million +11.1%5.1%4 $9.19 6/30/2023909,100 shares $9.41 million +38.5%4.6%3.8 $10.35 6/15/2023656,300 shares $8.07 million -23.0%3.3%2.7 $12.29 5/31/2023852,100 shares $8.44 million -9.8%4.3%4.6 $9.90 5/15/2023944,700 shares $11.16 million +29.3%4.8%5.4 $11.81 4/30/2023730,500 shares $8.47 million -1.8%3.7%4.3 $11.59 4/15/2023743,700 shares $7.16 million +16.3%3.8%5.8 $9.63 3/31/2023639,500 shares $5.91 million +2.3%3.3%5.6 $9.24 3/15/2023625,300 shares $6.02 million +5.5%3.3%6.3 $9.63 2/28/2023592,900 shares $6.11 million +2.8%3.1%6.7 $10.30 2/15/2023576,700 shares $5.29 million +1.2%3.0%6.4 $9.17 1/31/2023569,700 shares $5.92 million +0.0%3.0%6.6 $10.39 1/15/2023569,600 shares $4.88 million -15.2%2.9%7.7 $8.56 12/30/2022671,700 shares $5.96 million -0.2%3.5%8.9 $8.87 12/15/2022673,000 shares $5.32 million +0.1%3.5%10.2 $7.91 11/30/2022672,600 shares $5.76 million -1.0%3.5%10.3 $8.57 11/15/2022679,700 shares $6.17 million -9.5%3.5%10.5 $9.08 10/31/2022751,100 shares $8.90 million -31.7%3.9%13 $11.85 10/15/20221,100,000 shares $12.65 million -20.3%5.8%19.5 $11.50 9/30/20221,380,000 shares $11.48 million -3.5%7.2%25.6 $8.32Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW 9/15/20221,430,000 shares $13.46 million +1.4%7.5%15 $9.41 8/31/20221,410,000 shares $10.50 million -3.4%7.3%13 $7.45 8/15/20221,460,000 shares $12.64 million -0.7%7.6%10.3 $8.66 7/31/20221,470,000 shares $11.52 million -3.3%7.7%8.9 $7.84 7/15/20221,520,000 shares $13.77 million -10.6%7.9%8.4 $9.06 6/30/20221,700,000 shares $13.92 million -22.0%8.9%8.7 $8.19 6/15/20222,180,000 shares $14.72 million -10.7%11.4%10.6 $6.75 5/31/20222,440,000 shares $12.98 million +3.4%12.7%14.6 $5.32 5/15/20222,360,000 shares $14.04 million +3.5%12.3%15.8 $5.95 4/30/20222,280,000 shares $16.10 million +10.1%11.9%17 $7.06 4/15/20222,070,000 shares $16.21 million +4.6%10.8%15.7 $7.83 3/31/20221,980,000 shares $17.25 million -10.0%10.4%14.9 $8.71 3/15/20222,200,000 shares $18.55 million -0.5%11.6%16.7 $8.43 2/28/20222,210,000 shares $13.26 million +11.1%11.7%15.8 $6.00 2/15/20221,990,000 shares $14.23 million No Change10.5%14.5 $7.15 1/31/20221,990,000 shares $15.36 million +7.6%10.5%12.8 $7.72 1/15/20221,850,000 shares $15.71 million +2.2%9.8%12.2 $8.49 12/31/20211,810,000 shares $17.21 million -4.2%9.5%13.8 $9.51 12/15/20211,890,000 shares $19.18 million +3.9%9.9%16.3 $10.15 11/30/20211,820,000 shares $22.00 million +11.0%9.6%17.9 $12.09 11/15/20211,640,000 shares $24.17 million -6.3%8.6%16.8 $14.74 10/29/20211,750,000 shares $30.10 million -0.6%9.2%22.4 $17.20 10/15/20211,760,000 shares $29.96 million -4.9%9.3%20.8 $17.02 9/30/20211,850,000 shares $31.12 million -10.2%9.8%16.5 $16.82 9/15/20212,060,000 shares $31.37 million -6.8%10.9%16.1 $15.23 8/31/20212,210,000 shares $38.94 million -0.5%11.7%16.3 $17.62 8/13/20212,220,000 shares $33.59 million +7.8%11.7%16.1 $15.13 7/30/20212,060,000 shares $31.93 million -1.4%10.9%13.8 $15.50 7/15/20212,090,000 shares $32.19 million -1.9%11.1%14.8 $15.40 6/30/20212,130,000 shares $32.53 million -6.2%11.3%16.1 $15.27 6/15/20212,270,000 shares $38.79 million -7.4%12.0%17.4 $17.09 5/28/20212,450,000 shares $43.17 million +5.2%13.0%16.2 $17.62 5/14/20212,330,000 shares $35.84 million -0.4%12.3%13 $15.38 4/30/20212,340,000 shares $47.20 million -1.3%12.4%12.9 $20.17 4/15/20212,370,000 shares $41.78 million +1.7%12.5%12 $17.63 3/31/20212,330,000 shares $43.15 million -4.9%12.3%11.2 $18.52 3/15/20212,450,000 shares $48.00 million -11.2%12.9%11.1 $19.59 2/26/20212,760,000 shares $55.89 million +1.5%14.7%13.6 $20.25 2/12/20212,720,000 shares $70.94 million +3.8%14.5%14.8 $26.08 1/29/20212,620,000 shares $58.61 million -0.8%13.9%14.6 $22.37 1/15/20212,640,000 shares $55.26 million -1.9%14.0%15.3 $20.93 12/31/20202,690,000 shares $48.66 million +8.9%14.3%17.4 $18.09 12/15/20202,470,000 shares $45.97 million -9.5%13.1%17.9 $18.61 11/30/20202,730,000 shares $55.97 million +2.6%14.4%21.2 $20.50 10/30/20203,010,000 shares $69.20 million -3.8%16.0%20.1 $22.99 10/15/20203,130,000 shares $70.77 million -1.6%16.6%20.5 $22.61 9/30/20203,180,000 shares $61.34 million -0.6%16.9%20.5 $19.29 9/15/20203,200,000 shares $70.43 million +2.9%17.0%20.1 $22.01 8/31/20203,110,000 shares $78.03 million -0.6%16.5%19.7 $25.09 8/14/20203,130,000 shares $71.83 million +2.3%16.6%21 $22.95Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW 7/31/20203,060,000 shares $67.60 million +2.3%17.0%18.9 $22.09 7/15/20202,990,000 shares $70.89 million +5.7%16.7%15.8 $23.71 6/30/20202,830,000 shares $73.92 million +5.2%15.9%11.7 $26.12 6/15/20202,690,000 shares $71.55 million -2.9%15.1%10.6 $26.60 5/29/20202,770,000 shares $66.48 million +1.8%16.1%10 $24.00 5/15/20202,720,000 shares $67.05 million +3.0%15.8%9.9 $24.65 4/30/20202,640,000 shares $64.34 million +3.1%14.2%10.2 $24.37 4/15/20202,560,000 shares $53.86 million +10.3%14.9%11 $21.04 3/31/20202,320,000 shares $41.39 million +9.1%13.5%11.9 $17.84 3/13/20202,126,500 shares $45.29 million -11.8%13.4%9.7 $21.30 2/28/20202,410,000 shares $39.09 million +1.3%15.1%14.7 $16.22 2/14/20202,380,000 shares $65.83 million -0.8%14.0%14.8 $27.66 1/31/20202,400,000 shares $68.26 million +13.2%14.1%14 $28.44 1/15/20202,120,000 shares $63.54 million +17.8%12.5%11.8 $29.97 12/31/20191,800,000 shares $54.81 million -24.4%10.6%11 $30.45 URGN Short Interest - Frequently Asked Questions What is UroGen Pharma's current short interest? Short interest is the volume of UroGen Pharma shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 4,470,000 shares of URGN short. Learn More on UroGen Pharma's current short interest. What is a good short interest ratio for UroGen Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. URGN shares currently have a short interest ratio of 14.0. Learn More on UroGen Pharma's short interest ratio. Is UroGen Pharma's short interest increasing or decreasing? UroGen Pharma saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 4,470,000 shares, an increase of 0.9% from the previous total of 4,430,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does UroGen Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to UroGen Pharma: Akebia Therapeutics, Inc. (5.58%), Puma Biotechnology, Inc. (8.63%), RAPT Therapeutics, Inc. (8.91%), Marinus Pharmaceuticals, Inc. (8.90%), MannKind Co. (13.13%), AbCellera Biologics Inc. (9.58%), Day One Biopharmaceuticals, Inc. (17.50%), Mirum Pharmaceuticals, Inc. (18.69%), Calliditas Therapeutics AB (publ) (0.03%), Collegium Pharmaceutical, Inc. (21.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short UroGen Pharma stock? Short selling URGN is an investing strategy that aims to generate trading profit from UroGen Pharma as its price is falling. URGN shares are trading up $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against UroGen Pharma? A short squeeze for UroGen Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of URGN, which in turn drives the price of the stock up even further. How often is UroGen Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including URGN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Akebia Therapeutics Short Interest Data Puma Biotechnology Short Interest Data RAPT Therapeutics Short Interest Data Marinus Pharmaceuticals Short Interest Data MannKind Short Interest Data AbCellera Biologics Short Interest Data Day One Biopharmaceuticals Short Interest Data Mirum Pharmaceuticals Short Interest Data Calliditas Therapeutics AB (publ) Short Interest Data Collegium Pharmaceutical Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:URGN) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBill Clinton Backing Biden Replacement???The Freeport SocietyGet out of dollars—get into America’s new money insteadStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist My Default Watchlist Adding UroGen Pharma Ltd. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
